ArticleJPhys photonics2025
Isolating subsurface fluorescence in macroscopic lifetime imaging via high-spatial-frequency structured illumination.
Article in JPhys photonics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Enhancing Fluorescence Lifetime Imaging With Differential Transformer.Journal of biophotonics · 2026Article
- Real-time wide-field fluorescence lifetime imaging via single-snapshot acquisition for biomedical applications.PhotoniX · 2025Article
- Fluorescence molecular imaging technology: a promising new strategy for the diagnosis and treatment of gynecologic tumors.Frontiers in bioengineering and biotechnology · 2025Review
Corrections and comments
- Update of
Authors and funding
9 authors.
Funding
Abstract
Macroscopic fluorescence lifetime imaging (MFLI) has emerged as a robust, non-invasive imaging technique offering quantitative insights into physiological and molecular processes within live tissues, independent of fluorophore concentration, excitation intensity, or signal attenuation. However, a key limitation is the inability to accurately determine the depth at which fluorescence signals originate, potentially compromising biological interpretation due to ambiguous localization. In this study, we introduce high spatial frequency-fluorescence lifetime imaging (HSF-FLI), an innovative optical correction methodology designed to effectively eliminate surface signal bias, such as those arising from skin in preclinical imaging, without requiring chemical clearing agents. We develop a modulation transfer function linking spatial frequency with signal penetration depth through comprehensive Monte Carlo eXtreme simulations. Utilizing structured, three-phase sinusoidal illumination, fluorescence signals were accurately decomposed into distinct surface and subsurface components. Experimental validation was performed using agar-based capillary phantoms and a time-gated intensified charged coupled device coupled with a digital micromirror device imaging system. Further demonstrating its practical utility, we successfully applied HSF-FLI to preclinical drug delivery assessments employing Förster resonance energy transfer MFLI. The method was rigorously validated
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.